Catalent.com
Contact Us
  • Biologics
    • Integrated Solutions
    • Drug Substance
    • Drug Product
    • Analytical Services
  • Gene Therapy
    • Integrated Solutions
    • Process Development
    • CGMP Manufacturing
    • Analytical Services
  • Cell Therapy
    • Integrated Solutions
    • iPSCs
    • Process Development
    • CGMP Manufacturing
    • Analytical Services
    • Cell Type Solutions
  • Specialty
    • Bioconjugates
    • Bispecifics
    • Plasmid DNA
    • mRNA
    • Vaccines
    • Oncolytic Viruses
    • Orphan Drugs
  • Technologies
    • Cell Line Development (GPEX®)
    • Antibody Drug Conjugates (SMARTag®)
    • AAV Vectors
  • Expert Content
    • Biologics Analytical Services
    • Biologics Development
    • Drug Substance Manufacturing
    • Drug Product Manufacturing
    • Cell Therapy
    • Gene Therapy
    • Subscribe
  • About Us
    • Overview
    • News & Events
    • Our Leadership
    • Locations
    • Site Tours
  • Careers
Contact Us
Main menu
  • Biologics
    • Integrated Solutions
    • Drug Substance
    • Drug Product
    • Analytical Services
  • Gene Therapy
    • Integrated Solutions
    • Process Development
    • CGMP Manufacturing
    • Analytical Services
  • Cell Therapy
    • Integrated Solutions
    • iPSCs
    • Process Development
    • CGMP Manufacturing
    • Analytical Services
    • Cell Type Solutions
  • Specialty
    • Bioconjugates
    • Bispecifics
    • Plasmid DNA
    • mRNA
    • Vaccines
    • Oncolytic Viruses
    • Orphan Drugs
  • Technologies
    • Cell Line Development (GPEX®)
    • Antibody Drug Conjugates (SMARTag®)
    • AAV Vectors
  • Expert Content
    • Biologics Analytical Services
    • Biologics Development
    • Drug Substance Manufacturing
    • Drug Product Manufacturing
    • Cell Therapy
    • Gene Therapy
    • Subscribe
  • About Us
    • Overview
    • News & Events
    • Our Leadership
    • Locations
    • Site Tours
  • Careers
  • Catalent.com
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Analytical Services
  6.  » Pharma Predictions for 2021

Pharma Predictions for 2021

Summary: In a return to our popular event during JP Morgan 2020, Endpoints Editor John Carroll sat down with Catalent CEO John Chiminski to talk about the year ahead, offering their projections for what 2021 holds in store for the biopharma industry.

 

Click here to download the Webinar

Contact Us
Expert Content Subscribe Investors Contact Us Site Map
Follow Us. Share Us.
By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement | Cookies Settings.
Copyright 2022, Catalent, Inc - All Rights Reserved
Terms Modern Slavery Statement
Copyright 2020, Catalent, Inc - All Rights Reserved